secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0001295947-23-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q3 revenue $275.5M (+0.4%), EPS $1.04 (+5.1%); guides FY23 EPS ~$4.18
------------------------------------------------------------------------------

- Q3 revenue $275.5M (+0.4% YoY; +1.8% ex-currency); diluted EPS $1.04 (+5.1% vs $0.99).
- International OTC revenue $38.6M (+15% YoY); North American OTC $236.9M (-1.7%).
- Leverage ratio reduced to 3.5x, lowest in over 10 years; net debt ~$1.4B.
- FY2023 guidance: revenue $1,120-1,122M, diluted EPS ~$4.18, free cash flow ~$220M.
- Nine-month revenue $841.9M (+2.7% YoY); net income $158.2M vs $153.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594723000006/0001295947-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594723000006/pbh-20230202.htm
  HTML page:      https://secwatch.observer/filing/0001295947-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer